Prevalence of mupirocin resistance in Staphylococcus pseudintermedius.
Academic Article
Overview
Research
Identity
Additional Document Info
Other
View All
Overview
abstract
In the United States, veterinary use of mupirocin is primarily limited to the treatment of canine pyoderma caused by methicillin-resistant Staphylococcus pseudintermedius (MRSP). In this study, only 1 of 581 S. pseudintermedius isolates tested was resistant to mupirocin and carried the high-level mupirocin resistance gene, ileS2, on a plasmid.